You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

32 Results
Guidelines and Advice
Status: Current
ID: 4-16
Version: 3
May 2025
Drug
Other Name(s): Neupogen®, Grastofil®, Nivestym®, Nypozi®, Filra™
Sep 2025
Drug
Other Name(s): Efudex® Cream , IV generic brands available
Sep 2025
Drug
Other Name(s): Euflex®
Aug 2025
Drug
Other Name(s): Faslodex®
Aug 2025
Drug
Other Name(s): Femara®
Sep 2025
Drug
Other Name(s): Tykerb®
Sep 2025
Drug
Other Name(s): Lupron® , Lupron Depot® , Eligard®
May 2025
Regimen
Intent: Adjuvant
Funding:
ODB - General Benefit
    letrozole
Aug 2025
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    letrozole
Aug 2025
Regimen
Cancer Type:
Genitourinary, 
Prostate
Intent: Neoadjuvant, Adjuvant, Palliative
Funding:
ODB - General Benefit
    leuprolide - long-acting formulation
May 2025
Regimen
Intent: Palliative
Funding:
ODB - General Benefit
    fulvestrant
Aug 2025

Pages